The impact of negative growth in the first quarter of the global economy on the price and market of a nucleic acid
The global economy recorded its first quarter of negative growth in April-June since the coronavirus pandemic began two years ago, as headwinds ranging from surging inflation in the West to zero coronavirus restrictions in China increasingly weighed on activity.
Inflation, in particular, is a fault line in the world economy that will only widen if there is a crisis in Taiwan or elsewhere. The US and Europe now face a test of whether they can continue to lead global markets as they try to wean themselves off cheap Russian energy and Chinese Labour.
The global economy contracted between April and June, according to the IMF, with Yoshimasa Maruyama of Sumitomo Mitsui Banking Corporation Nikko Securities estimating that global GDP fell by 2.7%.
The United States, Germany and the United Kingdom recorded negative growth. Under a narrow technical definition, the United States is now in recession after its gross domestic product fell for the second quarter in a row. The Bank of England forecast earlier this month that Britain would enter recession between October and December and experience an economic contraction until 2023.
In a Nikkei survey of 10 private-sector economists, three expect the U.S. to enter a recession this year or in the first half of 2023, while six forecasts the same for the eurozone.
Japan's real gross domestic product grew 2.2 percent year-on-year in April-June, returning to pre-pandemic levels. But little of that growth is domestic, and potential growth remains low. A drop in overseas demand could derail its economy.
The forecasts come as demand for the digital devices and services that have led the world's post-COVID recovery begins to slow.
Buy high quality and effective DNA & RNA nucleic acid extraction reagent, lab consumables, automatic nucleic acid extractions, real-time PCR equipment and consumables or a nucleic acid . Welcome to contact GENETURE or Send an email to: firstname.lastname@example.org and our professional sales engineer will get back to you within 48 hours.
Analysis and forecast of the market size of PCR diagnostic industry
Polymerase chain reaction (PCR) is a nucleic acid synthesis technology that uses the principle of DNA double-strand replication to replicate specific DNA fragments in vitro. With this technology, the detection equipment can amplify the target gene in a large number in a short time, expanding the target gene fragment to the order of millions to billions, thus achieving high sensitivity detection. At present, polymerase chain reaction (PCR) diagnosis of infectious diseases such as hepatitis, venereal disease, intestinal respiratory disease and tumor single gene detection is an important application field. In 2020, polymerase chain reaction (PCR) diagnostic technology was identified as the "gold standard" for COVID-19 diagnosis due to its high sensitivity and accuracy.
China's PCR diagnostic market is developing rapidly, with the market size growing rapidly from about RMB 2.37 billion in 2015 to about RMB 5.93 billion in 2019, with a compound annual growth rate of 25.8%. China's PCR industry experienced explosive growth due to the huge demand for testing caused by the outbreak of COVID-19 in 2020, and the market size of China's PCR diagnostic industry exceeded 10 billion yuan in 2020. With the introduction of a large number of PCR diagnostic instruments, the PCR diagnostic industry will enter a new stage of development. It is expected that the PCR diagnostic industry will maintain a double-digit growth rate, and the market size of the PCR diagnostic industry will reach about 23.42 billion yuan in 2030 based on the factory price, and the cagR will reach about 13.3% from 2019 to 2030.
Market Demand of the a nucleic acid
The DNA/RNA Extraction Kit market and other a nucleic acid s are projected to grow at a CAGR of 8.26% during the forecast period 2022-2027.
The COVID-19 pandemic has impacted the a nucleic acid market for a short time due to restrictions on different business and research activities for a nucleic acid s. In addition, diagnostic tests for other diseases and medical conditions in hospitals and other clinical diagnostic facilities have been affected as COVID-19 has led to fewer patients taking tests. However, the high rate of COVID-19 infection and research activities are undertaken by major companies in the field of sequencing to expand their understanding of the virus and its origins, as well as molecular diagnostics of the SARS-COV-2 virus, have led to the development and launch of many DNA - and RNA-BASED COVID-19 kits, The kits proved so important that they were in great demand.
Market drivers for the a nucleic acid
The growth of the DNA/RNA extraction kit market is primarily driven by increased investment in R&D activities in different areas, including molecular diagnostics for different chronic and infectious diseases. For example, the US spent $842 billion on R&D activities in 2020, followed by China at $664 billion, according to the ORGANISATION for Economic Co-operation and Development. Technological advances worldwide, new product launches by major market players, and an increase in cancer cases are also likely to complement the growth of the markets under study.
Other factors, such as increased demand for automation of DNA/RNA extraction technologies, new user-friendly and easy extraction kits, and DNA/RNA for analysis of new diseases causing microorganisms, are expected to drive DNA/RNA growth. RNA Extraction Kit market during the forecast period. Therefore, low awareness and availability of the kit and low market penetration in less developed and developing regions around the world are the major factors limiting the growth of the DNA/RNA extraction kit market.
North America is expected to dominate the global a nucleic acid market during the forecast period
North America, which holds a major share in the a nucleic acid market, is expected to show a similar trend during the forecast period, mainly due to the high level of R&D activity in the region and the presence of major market players in the region constantly developing their products for the markets studied.
In the region, the US is expected to take a major share of the DNA/RNA extraction kit market due to heavy investment in R&D by government and private entities, increased demand for a nucleic acid s, and the rising prevalence of chronic diseases.
The a nucleic acid professional supplier manufacturer -Geneture
Geneture is a professional supplier of Nucleic Acid Extraction Reagent,Automatic Nucleic Acid Extraction,Lab consumables, Real-time PCR, Covid-19 Rapid Test Supplier. Buy high quality and effective DNA & RNA nucleic acid extraction reagent, lab consumables, automatic nucleic acid extractions, real-time PCR equipment and consumables.
Feel free to get a qutoe send an email to: i email@example.com and our professional sales engineer will get back to you within 48 hours.
Recently, some countries are short of electricity, or seek energy solutions, will this affect the bhutan itinerary 10 days ?…
The world's coal bosses and oil barons are among the biggest winners in 2022, as the fortunes of many tech giants have tumbled in the U.S. stock market. India's most powerful coal boss, Gautam Adani, has a net worth of $146.8 billion, pushing him pas…
OPEC+, an oil producers' alliance led by Saudi Arabia and Russia, stuck to its original plan to increase output by just 432,000 b/d in June, continuing to defy calls from major consumers led by the United States to pump more oil to keep prices down.…